Evidence map›Paper›PMID 31938754›Full record

ArticleContemporary clinical trials communications2020

A multicenter randomized clinical trial to evaluate the efficacy of telemonitoring in patients with advanced heart and lung chronic failure. Study protocol for the ATLAN_TIC project.

Carlos Hernandez-Quiles, Máximo Bernabeu-Wittel, Maria Del Rocio Garcia-Serrano, Salvador Vergara-Lopez, Jose Antonio Perez-de-Leon, Alberto Ruiz-Cantero, Wilfredo Lopez-Jimeno, Manuel Quero-Haro, Eusebio Terceño-Rodriguez, Remedios Garcia-Jimenez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Carlos Hernandez-QuilesDepartment of Internal Medicine, Hospital Universitario Virgen Del Rocio, Seville, Spain.
Máximo Bernabeu-WittelDepartment of Internal Medicine, Hospital Universitario Virgen Del Rocio, Seville, Spain.
Maria Del Rocio Garcia-SerranoDepartment of Internal Medicine, Hospital Universitario Virgen Del Rocio, Seville, Spain.
Salvador Vergara-LopezDepartment of Internal Medicine, Hospital Universitario de Valme, Sevilla, Spain.
Jose Antonio Perez-de-LeonDepartment of Internal Medicine. La Serranía Hospital, Ronda, Málaga, Spain.
Alberto Ruiz-CanteroInternal Medicine Clinical Administration Unit, Virgen Macarena University Hospital, Seville, Spain.
Wilfredo Lopez-JimenoSalud Responde (Healthline), Jaén, Spain.
Manuel Quero-HaroSalud Responde (Healthline), Jaén, Spain.
Eusebio Terceño-RodriguezAndalusian Agency for Social. Services and Dependency, Spain.
Remedios Garcia-JimenezDepartment of Internal Medicine, Complejo Hospitalario de Jaén, Jaen, Spain.
Bosco Baron-FrancoDepartment of Internal Medicine, Hospital Universitario Virgen Del Rocio, Seville, Spain.
Manuel Ollero-BaturoneDepartment of Internal Medicine, Hospital Universitario Virgen Del Rocio, Seville, Spain.
Hospital Universitario Virgen del Rocío · ESAndalusian Agency for Healthcare Quality · ESComplejo Hospitalario de Jaén · ESHospital La Inmaculada · ESHospital Universitario de Valme · ESHospital Universitario Virgen Macarena · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUsing technologies of information and communication (TICs) is emerging in medical assistance. TICs application for medical assistance is promising. Its applicability in advanced heart and/or respiratory failure is still controversial because studies have shown methodological weakness which could put in danger their conclusions. Our objective is to evaluate efficacy of the application of home monitoring biological parameters in a multi-level model of coordinated clinical care for patients with chronic diseases with advanced heart (HF) and/or respiratory failure (RF) in comparison with conventional clinical care.

method/Design: Multicentric, phase III, randomized, parallel groups, controlled clinical trial. Patients with advanced HF and/or RF were eligible to participate. Patients received medical assistance by a multi-level model of coordinated clinical care with or without home monitoring. Follow up was performed until 180 days after inclusion. Primary efficacy outcome was defined as the percentage of patients with hospitalization/emergency room visits. Secondary efficacy outcomes were hospital admissions, admissions to hospital emergencies and Primary Care Emergencies, number of days of hospital stay, total cost per patient in euros, mortality, change in functional status, quality of life, assistance and technology devices. Intention to treat, as well as per protocol, and incremental cost-effectiveness analysis will be performed. The number of recruits patients per arm is set at 255, a total of 510 patients. DISCUSSION: This trial could provide some knowledge about the real impact of home monitoring for patients with advanced HF and/or RF within a multi-level model of integrated care.

Indexed as

Chronic complex diseasese healthHome monitoringMultimorbidity

Identifiers

PMID31938754
PMCPMC6953642
OpenAlexW2998410456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.